Aerie Pharmaceuticals Inc (AERI) Inventory Turnover Ratio, from third quarter 2022 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Aerie Pharmaceuticals Inc   (NASDAQ: AERI)
 

Aerie Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aerie Pharmaceuticals Inc 's inventory turnover ratio, the ratio that measures Aerie Pharmaceuticals Inc 's ability to manage its supply chain, sequentially decreased to 0.54 in the third quarter 2022, which does not come as a surprise, as the Aerie Pharmaceuticals Inc continue to experience headwinds, which also impact its supply chain. Aerie Pharmaceuticals Inc 's average inventory processing period in the Sep 30 2022 quarter, has increased to 676 days, from 589 days, in the Jun 30 2022 quarter.

Within Healthcare sector 427 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2022, to 1920, from total ranking in the second quarter 2022 at 2046.

AERI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aerie Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AERI Inventory Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Inventory Growth 55.59 % 53.1 % 41.89 % 49.34 % 44.2 %
Y / Y Cost of Sales Growth -12.28 % -39.44 % 1.19 % -7.1 % 46.79 %
Inventory Turnover Ratio (TTM) 0.54 0.62 0.76 0.83 0.94
AERI's Total Ranking # 1920 # 2046 # 2003 # 1865 # 2045
Average inventory processing period 676 587 479 440 388
Seq. Inventory Growth -0.52 % 16.96 % -0.54 % 34.45 % -2.11 %
Seq. Cost of Sales Growth 85.22 % -44.82 % 11.7 % -23.15 % 27.88 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 428
Overall Market # 1920

Inventory Turnover Ratio Statistics
High Average Low
4.83 1.82 0.54
(Dec 31 2018)   (Sep 30 2022)



AERI Company Profile >> Back to AERI Efficiency Comparisons >> Compare AERI Inventory Turnover Ratio to its Competitors

Financial Statements
Aerie Pharmaceuticals Inc 's Inventories $ 47 Millions Visit AERI's Balance sheet
Aerie Pharmaceuticals Inc 's Cost of Revenues TTM $ 24 Millions Visit AERI's Income Statement
What are AERI's Sales? Visit AERI's Sales by Segment

Other Inventory Turnover Ratios
Aerie Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AERI's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AERI's Competitors
Inventory Turnover Ratio for AERI's Suppliers
Inventory Turnover Ratio for AERI's Customers

You may also want to know
AERI's Sales Growth Rates AERI's Pe Price to earnings ratio AERI's Receivables Turnover Ratio AERI's Stock Quote
AERI's Net Income Growth Rates AERI's Ps Price to Sales ratio AERI's Sales per Employee AERI's Asset Turnover Ratio
AERI's Net Margin AERI's Pb Price to Book ratio AERI's Financial Strength Ratios AERI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2022 Inventories at quarter ending Sep 30 2022
Alnylam Pharmaceuticals Inc   1.38 $ 127.637  Millions$ 92  Millions
Tenon Medical Inc   1.38 $ 0.848  Millions$ 1  Millions
Ultragenyx Pharmaceutical Inc   1.38 $ 26.510  Millions$ 19  Millions
Sunshine Biopharma Inc   1.37 $ 0.262  Millions$ 0  Millions
Minerva Surgical Inc   1.37 $ 22.439  Millions$ 16  Millions
Rapid Micro Biosystems Inc   1.36 $ 25.610  Millions$ 19  Millions
Stablecoin Development Corporation  1.35 $ 5.038  Millions$ 4  Millions
Vapotherm Inc   1.35 $ 50.473  Millions$ 37  Millions
Grapefruit Usa Inc   1.35 $ 0.490  Millions$ 0  Millions
Tela Bio Inc   1.34 $ 13.548  Millions$ 10  Millions
Seagen Inc   1.34 $ 388.538  Millions$ 290  Millions
Thermogenesis Holdings Inc   1.33 $ 7.225  Millions$ 5  Millions
Nevro Corp   1.33 $ 125.021  Millions$ 94  Millions
Scientific Industries Inc   1.33 $ 5.644  Millions$ 4  Millions
Zomedica Corp   1.30 $ 4.435  Millions$ 3  Millions
Axogen inc   1.29 $ 23.434  Millions$ 18  Millions
Macrogenics Inc   1.28 $ 4.182  Millions$ 3  Millions
Nektar Therapeutics  1.28 $ 21.565  Millions$ 17  Millions
Nephros Inc   1.26 $ 5.572  Millions$ 4  Millions
Protalix Biotherapeutics inc   1.24 $ 20.343  Millions$ 16  Millions
Veru Inc   1.24 $ 8.763  Millions$ 7  Millions
Asensus Surgical Inc   1.23 $ 10.861  Millions$ 9  Millions
Electromedical Technologies Inc   1.22 $ 0.212  Millions$ 0  Millions
Lakeland Industries Inc   1.22 $ 64.482  Millions$ 53  Millions
Paratek Pharmaceuticals Inc   1.21 $ 17.461  Millions$ 14  Millions
Myovant Sciences Ltd   1.21 $ 17.713  Millions$ 15  Millions
Transmedics Group Inc   1.19 $ 20.197  Millions$ 17  Millions
Siga Technologies Inc  1.19 $ 24.823  Millions$ 21  Millions
Avinger Inc   1.19 $ 5.992  Millions$ 5  Millions
Vystar Corporation  1.18 $ 3.048  Millions$ 3  Millions

Date modified: 2026-08-29T17:18:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.